The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict DR Horton's revenues will grow 32.9% and EPS will grow 46.2%.
The average estimate for revenue is $1.28 billion. On the bottom line, the average EPS estimate is $0.19.
Last quarter, DR Horton tallied revenue of $1.28 billion. GAAP reported sales were 41% higher than the prior-year quarter's $906.6 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $0.20. GAAP EPS of $0.20 for Q1 were 122% higher than the prior-year quarter's $0.09 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 19.6%, 260 basis points better than the prior-year quarter. Operating margin was 8.6%, 470 basis points better than the prior-year quarter. Net margin was 5.2%, 210 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $6.21 billion. The average EPS estimate is $1.04.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 586 members out of 1,139 rating the stock outperform, and 553 members rating it underperform. Among 297 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 157 give DR Horton a green thumbs-up, and 140 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on DR Horton is outperform, with an average price target of $21.23.
The rich are different than you and me: They might not notice the moneymaking stories right under our noses. In our new report, "Middle-Class Millionaire-Makers: 3 Stocks Wall Street's Too Rich to Notice," we give you three Peter Lynch-inspired buy-what-you-know stocks for the 99%. Click here for instant access to this free report.
- Add DR Horton to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.